kaplan 2010 step 2 CK Pulmonology ch. 10 08 Pulmonary Thromboembolism.flv kaplan 2010 step 2 CK
Systems-based Approach to Preventing Venous Thromboembolism (VTE) UW Health vascular surgeon Dr. John Hoch explains what occurs in a venous thromboembolism and University of Wisconsin Hospital's initiative to reduce the occurrence of this disease that can result in long-term complications. Through a systems-based approach with multiple disciplines and the use of alerts in medical records, UW Hospital has dramatically reduced the incidence of venous thromboembolism.
Risk Factors for VTE The QThrombosis online calculator will estimate the risk for development of venous thromboembolism (VTE) in your patients. Watch this short video for more information about the risks for VTE and the 5 A approach to preventing VTE. From David W. Woodruff, MSN, RN-BC, CNS, CEN, of Ed4.
Radiology video: Cavitating Lung Lesions in Chronic Thromboembolic Pulmonary Hypertension - This is aRadiology video from the Journal of Radiology Case Reports (). The Journal of Radiology Case Reports provides uniquely interactive journal articles with scroll, window zoom and many more functions as known from your Radiology workstation. To watch more Radiology videos visit the affiliated Radiology network Radiolopolis () - the international Radiology community for education, research and clinical practice.
Prolonged Aspirin Use Prevented Recurrent Blood Clots After stopping anticoagulants, Italian investigators gave low-dose aspirin to patients who had unprovoked venous thromboembolism. In an interview at the annual meeting of the American Society of Hematology, Dr. Cecilia Becattini tells how this low-cost intervention cut recurrences by 40%.
Venous Thromboembolism (VTE): What Is This And What Are The Symptoms? - Dr. Atiemo Dr. Atiemo discusses venous thromboembolism and its symptoms. For more information on heart disease visit
Compression Stockings to Prevent VTE Venous thromboembolism is a preventable complication of immobility that is aggravated by hypercoaguable states caused by surgery, trauma, and infection. Postthrombotic syndrome (PTS) is associated with persistent leg swelling, pain, and skin discoloration. Compression elastic stockings are used to help prevent PTS and VTE. It is believed that thigh length elastic stockings would provide additional benefit by extending above the knee. In this study, the authors sought to determine if thigh length compression stockings were more effective than below knee stockings.
Part 5 - Everything You Ever Wanted to Know About Clotting Venous Thromboembolism, Genetic Predisposition, Acquired Trigger(s), Thrombosis, family history of blood clotting, genetic thrombophilia, Factor V Leiden, Prothrombin Gene Mutation, Protein C deficiency, Protein S deficiency, Antithrombin-III deficiency, Dysfibrinogenemia,Autosomal dominant inheritance (Slides 16 - 20).
Thepairinja Venous Thromboembolism in Oncology Patients 1 Reference: The lecture given by Dr. Krittika Tanyasaensook, Department of Clinical Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand. Advances in Pharmacotherapeutics and Pharmacy Practice Conference 2011-2012. pp. 87-103.
ASA after Anticoagulation in Venous Thromboembolism
Thromboprophylaxis Guidelines in Hip or Knee Replacement Surgery Thromboprophylaxis Guidelines in Hip or Knee Replacement Surgery. The need for appropriate thromboprophylaxis following hip or knee replacement surgery is clearly documented in guidelines issued by a number of notable medical bodies. For example, The American College of Chest Physicians recommend thromboprophylaxis for 10 days in knee replacement patients, and up to 35 days following hip replacement. Yet the results of a recent Registry show that compliance with guideline recommendations is poor, leaving between 40 and 60% of patients undertreated. This is serious because we know that the incidence of venous thromboembolism increases in the days following surgery -- yet paradoxically thromboprophylaxis actually decreases during this time. We are missing the opportunity to prevent a large number of thromboembolic events by failing to conform to guideline recommendations. References: 1. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR. Prevention of venous thromboembolism. Chest. 2008;133:381S-453S 2. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events. J Bone Joint Surg [Br]. 2007;89-B:799-807
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients... Dr. Geoffrey C. Nguyen discusses his m***cript "Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study." To view the print version of this abstract go to tiny.cc
Venous Thromboembolism in Oncology Patients 4 Reference: The lecture given by Dr. Krittika Tanyasaensook, Department of Clinical Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand. Advances in Pharmacotherapeutics and Pharmacy Practice Conference 2011-2012. pp. 87-103.
Safer Healthcare Now! - Venous thromboembolism (VTE)
Thepairinja Venous Thromboembolism in Oncology Patients 2 Reference: The lecture given by Dr. Krittika Tanyasaensook, Department of Clinical Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand. Advances in Pharmacotherapeutics and Pharmacy Practice Conference 2011-2012. pp. 87-103.
Daiichi Sankyo Coagulation Center The Challenge Balancing the Dynamics of Thrombosis and Hemorrhage
Burton's Queen's Hospital's risk assessment tool for blood clots Each year more than 25000 people in England die from blood clots or venous thromboembolism (VTE) contracted in hospital. This is more than the combined total of deaths from breast cancer, AIDS and traffic accidents, and more than 25 times the amount of people who die from MRSA. At Queen's Hospital in Burton on Trent a team led by consultant Haematologist Dr Hume Ahmad, have developed a risk assessment tool to help staff identify people at risk of developing clots. Dr Ahmad says, 'We now have wonderful drugs that would prevent blood clots. What we need is to be able to identify those patients that are at risk of developing blood clots when they come to hospital.' The system works by asking 2 simple questions; is the patient at risk of a clot developing? If the answer is 'Yes' then the second question asks you; is it safe to prescribe clot preventing medicines? These questions are added to the assessment programme used by nurses when admitting patients. It's key is that it is built into the operational process, medical staff have to go through the process to proceed through the system. Ward sister Cheryl Chamberlain says, 'Every patient who is admitted, needs to have this assessment, it's very easy to use and it has been proved to reduce the incidence of patients developing Thromboembolism.'
Venous Thromboembolism Prophylaxis: Quality Improvement with a Systems Based Team Approach Presented by Saqib Zia, MD at the Department of Surgery Grand Rounds on 02/01/2012. Free CME may be available on the Deparment of Surgery website below after watching this video and completing a short course evaluation. www.surgery.wisc.edu
Facts about Venous Thromboembolism VTE impacts Facts about Venous Thromboembolism VTE impacts. Venous thromboembolism is common and often fatal. In the Western World every 8 seconds a person develops a venous thromboemblic event - that is just over 4 million cases every year. In the European Union alone, over half a million people die every year of venous thromboembolism when a blood clot becomes a pulmonary embolism. If we take into account deaths due to pulmonary embolism in the United States, total mortality in the Western World rises to over eight hundred thousand people per year. Other data from the United States show that venous thromboembolism is the immediate cause of death in up to ten per cent of all patients who die in hospitals. A European study, published in 2007, shows that venous thromboembolism causes twice as many deaths as are caused by AIDS, breast cancer, prostate cancer, and road traffic accidents combined. References: 1. 2. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA. Venous thromboembolism (VTE) in Europe. Thromb Haemost. 2007;98:756-764 3. Anderson FA, Zayaruzny M, Heit JA, Fidan D, Cohen AT. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82:777-782
Thepairinja Venous Thromboembolism in Oncology Patients 3 Reference: The lecture given by Dr. Krittika Tanyasaensook, Department of Clinical Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand. Advances in Pharmacotherapeutics and Pharmacy Practice Conference 2011-2012. pp. 87-103.
Rivaroxaban vs enoxaparin for the Prevention of Venous Thromboembolism.. Dr Alexander Cohen (King's College, London, UK) discusses rivaroxaban compared with enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients. Filmed during ACC 2011 in New Orleans, LA on April 4.
Venous Thromboembolism: A Nurse's Guide To Prevention And Management - Ellen Welch ll4.me Venous Thromboembolism: A Nurse's Guide To Prevention And Management - Ellen Welch Written primarily with nurses in mind, this book provides a comprehensive overview of venous thromboembolism, a condition that rears its head regardless of specialty, killing thousands of people around the world in hospital beds and in the community alike. This book explains what it is, what symptoms to watch out for, how patients should be managed, and perhaps most importantly, how to prevent its development in those at risk.Based on the most up to date published guidelines on the subject, the book is pitched at a level appropriate for medical and nursing staff alike, covering basic pathophysiology and clinical management. A chapter is devoted to specific nursing interventions, giving practical tips alongside the theory. Case studies are used extensively, alongside tables, diagrams and text boxes to illustrate important points.Although designed to be read as a whole, each chapter can be used as a reference to address specific queries enabling health professionals to develop a greater understanding of the condition to provide optimal patient care.Written primarily with nurses in mind, this book provides a comprehensive overview of venous thromboembolism, a condition that rears its head regardless of specialty, killing thousands of people around the world in hospital beds and in the community alike.This book explains what it is, what symptoms to watch out for, how patients should be ...
J Surg Rad | Massive Thromboembolism Captured By Real-Time Echocardiography Thromboembolism is a potentially serious complication following any surgical procedure. Its incidence is particularly high after elective orthopedic procedures, such as a total knee arthroplasty. We present a patient who developed a massive thromboembolism captured by real-time echocardiography, who was undergoing ultrasound as part of an unrelated clinical study. Rebecca A. Schroeder, MD Associate Professor Department of Anesthesiology, Duke University School of Medicine & Durham VAMC, Durham, North Carolina
.Thrombosis - What Is Thrombosis - Dangers of Arterial Plaque Video.mp4
Risk Factors for Venous Thromboembolism Interviewed Question: What risk factors for Venous Thromboembolism (VTE) are underappreciated or not consistently recognized? Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, BCPS (AQ Cardiology) Professor of Clinical Pharmacy Department of Pharmacy Practice and Pharmacy Administration Philadelphia College of Pharmacy University of the Sciences in Philadelphia Philadelphia, Pennsylvania Visit the highly interactive website for educational information, including: • Patient case studies • Tools to help evaluate bleed risk and stroke risk • Downloadable resources for your practice This video has been provided to you by Daiichi Sankyo, Inc. For United States Healthcare Professionals' educational purposes only.
Part 1 - Everything You Ever Wanted to Know About Clotting - Stop the Clot Forum The National Alliance for Thrombosis and Thrombophila Stop the Clot Forum. Guest speaker Mark T. Reding, MD, Assistant Professor of Medicine, Division of Hematology, Oncology, & Transplantation Director, Center for Bleeding and Clotting Disorders, University of Minnesota This segment defines: Hemostasis = normal blood clotting, Thrombosis = excessive blood clotting, Thrombophilia = predisposition to thrombosis, DVT = deep vein thrombosis (clot in leg), PE = pulmonary embolus (clot in lung), VTE = venous thromboembolism (DVTs and PEs),
Long-term Management of Venous Thromboembolism Venous thromboembolism is also a persistent problem that requires long-term management. Rates of recurrence are high, with more than one in five patients experiencing another VTE within 12 months of discontinuing treatment. The rate of hospital readmissions for deep vein thrombosis (DVT) is unacceptably high at 19%. References: Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340(12):901-907. Woodward T, Kachroo S, Bookhar BK, et al. Systematic review of the economic burden of venous thromboembolism treatment. Paper presented at ISPOR 15th Annual International Meeting; May 2010; Atlanta, GA. Abstract PCV60. Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007;147(11):766-774. Clexane [summary of product characteristics]: Guildford, Surrey, United Kingdom: sanofi-aventis; December 2011. Warfarin [summary of product characteristics]. Frimley, Camberley, Surrey, United Kingdom: Sandoz Ltd; October 2010.
CME: Best Practices in Venous Thromboembolism (VTE) Prophylaxis Applying the Guidelines to Patients with Cancer Module: "The best estimates indicate that 350000O to 600000 Americans each year suffer from DVT and PE, and that at least 100000 deaths may be directly or indirectly to these diseases." (The Surgeons General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2008). One fifth of all these VTE events occur in patients with cancer. Point of fact...cancer-associated thrombosis is the second leading cause of death in patients with cancer after cancer itself. In addition to the association with mortality, there are other serious consequences of VTE in the cancer patient....blood clots and bleeding complications. While guidelines for the prevention/prophylaxis VTE have existed since 1986 multiple studies, that have included hospital medical record audits, demonstrate underuse of VTE prophylaxis. Up to 2/3 of patients with hospital-acquired VTE did not receive appropriate prophylaxis. City of Hope DVT/PE Diagnosis ***ysis-January 2007 -- June 2009 demonstrate variations in care and delivery of care that have deviations is in practice compared with evidence-based recommendations for VTE prophylaxis. This live educational intervention is the first in a series of educational interventions to mitigate this performance practice gap at the City of Hope. Release date: March 30, 2010 A City of Hope Continuing Medical Education e-Learning Module To obtain CME credit and learn more about this module, visit ...
Aortic Thromboembolism _ Cat Silistra Veterinary Clinic
CME: A Call to Action for Improved Thromboprophylaxis & Venous Thromboembolism Management VTE, including deep venous thrombosis (DVT) is a common and often fatal complication in patients with cancer. Data demonstrates that patients with cancer have the lowest rate of VTE prophylaxis in both inpatient and ambulatory settings. Though proven, effective guidelines are available to prevent and treat DVT in such high risk patients, most who could benefit from such strategies do not benefit from them since too few health care professionals are aware of the evidence-based practices for identifying high risk patients and providing preventive, diagnostic or therapeutic services. Release date: March 21, 2011 A City of Hope Continuing Medical Education e-Learning Module To obtain CME credit and learn more about this module, visit To learn more about City of Hope Continuing Medical Education, visit To view more CME modules, go to ###################### CONNECT WITH CITY OF HOPE and more at ABOUT CITY OF HOPE City of Hope is a leading medical research, treatment and education center dedicated to preventing, treating and curing cancer, diabetes, HIV/AIDS and other life-threatening diseases. Our mission is to quickly turn research ideas into cures that help save patients' lives all over the world. Learn more at .
Prevention of Thromboembolism in surgical procedures Dr. Newall presents a paper on prevention of Thromboembolism in large volume liposuction and body contouring surgery. For more information please visit:
American College of Physicians: Preventing Venous Thromboembolism in Hospitalized Patients The American College of Physicians (ACP) recommends that doctors assess the risk of thromboembolism and bleeding in patients hospitalized for medical illnesses, including stroke, before initiating therapy to prevent venous thromboembolism (VTE). VTE, comprised of pulmonary embolism (PE) and deep venous thrombosis (DVT), is a serious, common clinical problem. Because most hospitalized patients have at least one VTE risk factor, many hospitals routinely give patients blood thinners. However, these medications increase the risk of bleeding. "The evidence does not support routine VTE prophylaxis in patients hospitalized for medical illnesses, including stroke," said Amir Qaseem, MD, FACP, PhD, MHA, Director of Clinical Policy at ACP. "If a patient is at risk for VTE, the American College of Physicians recommends that physicians prescribe heparin or related blood thinners, unless the assessed risk of bleeding outweighs likely benefits." In patients hospitalized for medical illnesses, including stroke, prevention with heparin is associated with a statistically significant reduction in PE events. In most cases, the clinical benefit of reducing PE events will outweigh the harm of increased risk of bleeding events, the guideline states. No differences in benefits or harms were found between the types of heparin used. If a patient is at risk for VTE and bleeding from blood thinners, ACP does not recommend using graduated compression stockings. The evidence showed that they were not ...
Using Statins to Prevent VTE Statins such as lipitor (atorvastatin) may play a crucial role in preventing venous thromboembolism through anti-thrombotic properties not related to cholesterol reduction. Video by David W. Woodruff, MSN, RN-BC, CNS, CEN of Ed4Nurses, Inc.
Lynda Bonner talks about the role of nurses in VTE prevention This interview was recorded at the Venous Thromboembolism (VTE) Leadership Summit on 30 March 2011.
Factor Xa Inhibition Mode of Action Factor Xa Inhibition Mode of Action Visit the highly interactive website for educational information, including: • Patient case studies • Tools to help evaluate bleed risk and stroke risk • Downloadable resources for your practice This video has been provided to you by Daiichi Sankyo, Inc. For United States Healthcare Professionals' educational purposes only.
Epidural Anesthesia as a Thromboembolitic Prophylaxis Modality in Plastic Surgery Epidural anesthesia (EA) is known to reduce postoperative thromboembolic complications, but the mechanisms are poorly understood. In the main article, the authors investigate the hypothesis that the differential nerve-blocking effect of bupivacaine, which spares motor function and permits leg movement during the operation, is most important mechanism by which EA prevents thromboembolism. In this video, the authors highlight the intraoperative leg movement technique utilized during their concurrent abdominoplasty procedures.
Histopathology Lung --Thromboembolus (also commonly called t Histopathology Lung --Thromboembolus (also commonly called thromboembolism)